These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 15380259)

  • 21. [Susceptibility and resistence of Pseudomonas aeruginosa to antimicrobial agents].
    Gamero Delgado MC; García-Mayorgas AD; Rodríguez F; Ibarra A; Casal M
    Rev Esp Quimioter; 2007 Jun; 20(2):230-3. PubMed ID: 17893761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa.
    Ray GT; Baxter R; DeLorenze GN
    Clin Infect Dis; 2005 Aug; 41(4):441-9. PubMed ID: 16028150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
    Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
    J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals.
    Eagye KJ; Nicolau DP
    Adv Ther; 2011 Apr; 28(4):326-33. PubMed ID: 21445549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.
    Cook PP; Das TD; Gooch M; Catrou PG
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):716-22. PubMed ID: 18590455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.
    Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE
    J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoroquinolone-resistant Pseudomonas aeruginosa in chronic rhinosinusitis.
    Guss J; Abuzeid WM; Doghramji L; Edelstein PH; Chiu AG
    ORL J Otorhinolaryngol Relat Spec; 2009; 71(5):263-7. PubMed ID: 19797934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.
    Wolter DJ; Smith-Moland E; Goering RV; Hanson ND; Lister PD
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):43-50. PubMed ID: 15380277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic sensitivity and plasmid profiles of Pseudomonas aeruginosa.
    Igumbor E; Gwanzura L; Chirara M; Obi C; Muza D
    Cent Afr J Med; 2000 Nov; 46(11):296-300. PubMed ID: 12002119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():17-32. PubMed ID: 15953020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of a hospital-wide programme of heterogeneous antibiotic use on the development of antibiotic-resistant Gram-negative bacteria.
    Takesue Y; Nakajima K; Ichiki K; Ishihara M; Wada Y; Takahashi Y; Tsuchida T; Ikeuchi H
    J Hosp Infect; 2010 May; 75(1):28-32. PubMed ID: 20346536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
    Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
    Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antimicrobial resistance in clinical patterns of Pseudomonas aeruginosa].
    del Mar Casal M; Causse M; Rodríguez-López F; Casal M
    Rev Esp Quimioter; 2012 Mar; 25(1):37-41. PubMed ID: 22488540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Implementation of antimicrobial resistance surveillance and antibiotic consumption in an intensive care burn department].
    Messadi AA; Thabet L; Bousselmi K; Oueslati S; Ben Redjeb S
    Tunis Med; 2008 May; 86(5):486-9. PubMed ID: 19469305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism.
    Ho SA; Lee TW; Denton M; Conway SP; Brownlee KG
    J Cyst Fibros; 2009 Jan; 8(1):43-6. PubMed ID: 18829398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic disc sensitivity pattern of pseudomonas aeruginosa isolates obtained from clinical specimens in Ilorin, Nigeria.
    Fadeyi A; Akanbi AA; Nwabuisi C; Onile BA
    Afr J Med Med Sci; 2005 Sep; 34(3):303-6. PubMed ID: 16749366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Susceptibility patterns and cross-resistance of antibiotics against Pseudomonas aeruginosa isolated from burn patients in the South of Iran.
    Japoni A; Alborzi A; Kalani M; Nasiri J; Hayati M; Farshad S
    Burns; 2006 May; 32(3):343-7. PubMed ID: 16527415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
    Manno G; Cruciani M; Romano L; Scapolan S; Mentasti M; Lorini R; Minicucci L
    Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-year report of national surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea (2002-2006).
    Yoo J; Sohn ES; Chung GT; Lee EH; Lee KR; Park YK; Lee YS
    Diagn Microbiol Infect Dis; 2008 Mar; 60(3):291-4. PubMed ID: 18068936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imipenem and ciprofloxacin consumption as factors associated with high incidence rates of resistant Pseudomonas aeruginosa in hospitals in northern France.
    Miliani K; L'Hériteau F; Lacavé L; Carbonne A; Astagneau P;
    J Hosp Infect; 2011 Apr; 77(4):343-7. PubMed ID: 21316805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.